Research Nurse Jennifer Cunningham, B.S.N., looks on as a healthy volunteer who receives an infusion of CIS43LS, an experimental monoclonal antibody against malaria, as part of Phase 1 clinical trial.

Read more about the study: https://www.nih.gov/news-events/news-releases/first-human-trial-monoclonal-antibody-prevent-malaria-opens

Public Domain Mark 1.0
Credit: National Institute of Allergy and Infectious Diseases, NIH